Showing results (1141-1150 of 1,295) with videos related to
Sort By:
Pageof 130
Journal of Comparative Effectiveness Research|April 29, 2017
The cost-effectiveness of blue-light therapy in the treatment of mild-to-moderate psoriasisAmir Ansaripour, Hok Bing Thio, Rob Maessen, et al.Journal of Comparative Effectiveness Research|May 10, 2017
Familial clustering of atrial fibrillation and comparative longitudinal outcomes of familial and non-familial atrial fibrillationAnna Gundlund, Jonas B Olesen, Eric D Peterson, et al.Journal of Comparative Effectiveness Research|May 10, 2017
Adoption of the HPV vaccine: a case study of three emerging countriesAraceli Caro Martínez, Jaime Espín Balbino, Alexandre Lemgruber, et al.Journal of Comparative Effectiveness Research|May 25, 2018
Budget impact of adding lesinurad for second-line treatment of gout: a US health plan perspectiveRobert W Klein, Shaum Kabadi, Frank N Cinfio, et al.Journal of Comparative Effectiveness Research|July 13, 2017
Indication-specific pricing of pharmaceuticals in the US healthcare systemSteven D Pearson, William B Dreitlein, Chris Henshall, et al.Journal of Comparative Effectiveness Research|April 24, 2018
Clinical and economic benefits of advanced microplegia delivery system in cardiac surgery: evidence from 250 hospitalsMarc W Gerdisch, Scott Robinson, Guy David, et al.Journal of Comparative Effectiveness Research|May 30, 2018
Effect of frailty on resource use and cost for Medicare patientsKit N Simpson, Bryant A Seamon, Brittany N Hand, et al.Journal of Comparative Effectiveness Research|May 30, 2018
Factors influencing dabigatran or warfarin medication persistence in patients with nonvalvular atrial fibrillationSrinivas Annavarapu, Pranav K Gandhi, Yong Li, et al.Journal of Comparative Effectiveness Research|September 6, 2016
Publicly funded practice-oriented clinical trials: of importance for healthcare payersMattias Neyt, Thierry Christiaens, Jacques Demotes, et al.Journal of Comparative Effectiveness Research|April 26, 2018
Cost-effectiveness of long-acting injectable aripiprazole once-monthly 400 mg in bipolar I disorder in the USAMargarida Augusto, Mallik Greene, Maëlys Touya, et al.Pageof 130